Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 126 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1251 9.7 months Advanced recurrent ovarian 4 Biologic therapy
Princess Margaret Hospital Canada 5/2007
Treatment Details: Patients: This phase II study evaluated 29 women with advanced recurrent ovarian cancer. The median age was 55 years, ranging from 23 to 72. All had received a previous chemotherapy regim
 
1252 9.7 months Advanced malignant pleural mesothelioma 4 Chemotherapy
Medical University of Gdansk Poland 4/2008
Treatment Details: Patients: This phase III study involved 243 patients with advanced malignant pleural mesothelioma. The majority of patients (189) were men. These patients ranged in age from 32 to 79 year
 
1253 9.7 months GBM 5 Biologic therapy
MD Anderson Cancer Center United States 7/2010
Treatment Details: Patients: This phase II study involved 48 patients with first-relapse glioblastoma. The median age of the patients was 51 years (range 37-73). Gender distribution was not reported. Tre
 
1254 9.7 months Unresectable localized or Metastatic NSCLC 4 Chemotherapy
Institut de Recherche Pierre Fabre France 6/2009
Treatment Details: Patients: This phase 2 study involved 56 patients with unresectable localized or metastatic non-small cell lung cancer. There were 39 men and 17 women in the study. Their median age was 6
 
1255 9.7 months Advanced melanoma 4 Chemotherapy
St. Luke's Hospital United States 6/2009
Treatment Details: Patients: This phase III trial involved advanced melanoma patients who had progressed following treatment with dacarbazine or temozolomide. Patients were divided into 2 separate treatment
 
1256 9.7 months Advanced melanoma 5 Biologic therapy
Chemotherapy
St. Luke's Hospital United States 6/2009
Treatment Details: Patients: This phase III trial involved advanced melanoma patients who had progressed following treatment with dacarbazine or temozolomide. Patients were divided into 2 separate treatment
 
1257 9.7 months NSCLC 4 Chemotherapy
Emory University United States 1/2010
Treatment Details: Patients: In this study, patients with advanced non-small-cell lung cancer were divided into two treatment groups. Group A consisted of 62 patients with a median age of 64 years, 61% of wh
 
1258 9.7 months Malignant pleural mesothelioma 5 Chemotherapy
Finsen Centre/National University Hospital Denmark 2/2007
Treatment Details: Patients: This study involved patients with malignant pleural mesothelioma who had previously been treated with platinum-based chemotherapy. Patients were divided into two separate treatme
 
1259 9.6 months Metastatic, castration-resistant prostate cancer 5 Chemotherapy
Centre Léon Bérard France 3/2011
Treatment Details: Patients: This study involved 56 men with metastatic castration-resistant prostate cancer. The median patient age was 67.7 years. Treatment: Patients in this study were treated with th
 
1260 9.6 months GBM 4 Immunotherapy
Surgery
University Hospital Leuven Belgium 5/2008
Treatment Details: Patients: This study involved 56 patients with relapsed glioblastoma multiforme. The median age was 45, ranging from 7-77 years of age. There were 36 males and 20 females in the study.
 
Page 126 of 187  | Previous Page  | Next Page